James M. Musser
James M. Musser publishes mostly in Infectious Diseases, Public Health, Environmental and Occupational Health and Epidemiology, on topics such as Streptococcal Infections and Treatments, Antimicrobial Resistance in Staphylococcus and Neonatal and Maternal Infections.
- World rank
- #14,161 of 7,710,434 ranked researchers
- Rank in United States
- #4,989 of 1,627,098
- Works
- 567
- Citations
- 50k
- Citations per work
- 88.3
What does James M. Musser research?
James M. Musser's work is mostly in Medicine (65%), Biochemistry, Genetics and Molecular Biology (9%), Immunology and Microbiology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences36664.6%
- Medicine36664.6%
- Everything else12622.2%
- Life Sciences7513.2%
- 1Infectious Diseases26% of their works
- 2Public Health, Environmental and Occupational Health24% of their works
- 3Epidemiology15% of their works
- 4Molecular Biology6% of their works
- 5Microbiology4% of their works
- 6Clinical Biochemistry4% of their works
Research topics
- Streptococcal Infections and Treatments
- Antimicrobial Resistance in Staphylococcus
- Neonatal and Maternal Infections
- Tuberculosis Research and Epidemiology
- Infective Endocarditis Diagnosis and Management
- Mycobacterium research and diagnosis
- Bacterial Identification and Susceptibility Testing
- Pneumonia and Respiratory Infections
Which keywords describe James M. Musser's research?
The keywords of their largest research topics: Epidemiology, Virulence Factors, Necrotizing Fasciitis, Streptococcus Pyogenes, Antimicrobial Resistance, Diagnosis, Treatment and MRSA.
- Pneumococcal Conjugate Vaccine
- Microorganism Identification
- Nontuberculous Mycobacteria
- Prophylaxis
- Tuberculosis
- Neonatal Sepsis
- Bacteremia
- MRSA
- Diagnosis
- Streptococcus Pyogenes
- Virulence Factors
- Epidemiology
- Necrotizing Fasciitis
- Antimicrobial Resistance
- Treatment
- Staphylococcus aureus
- Group B Streptococcus
- Mycobacterium tuberculosis
- Infective Endocarditis
- Mycobacterium avium
- Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry
- Community-Acquired Pneumonia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 22 words, with their numbers
- Epidemiology7726 topics
- Virulence Factors4842 topics
- Necrotizing Fasciitis2701 topic
- Streptococcus Pyogenes2701 topic
- Antimicrobial Resistance2562 topics
- Diagnosis2463 topics
- Treatment2463 topics
- MRSA2141 topic
- Staphylococcus aureus2141 topic
- Bacteremia1412 topics
- Group B Streptococcus1241 topic
- Neonatal Sepsis1241 topic
- Mycobacterium tuberculosis881 topic
- Tuberculosis881 topic
- Infective Endocarditis831 topic
- Prophylaxis831 topic
- Mycobacterium avium751 topic
- Nontuberculous Mycobacteria751 topic
- Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry581 topic
- Microorganism Identification581 topic
- Community-Acquired Pneumonia421 topic
- Pneumococcal Conjugate Vaccine421 topic
Where does James M. Musser work?
James M. Musser's main affiliation in the publication record is Houston Methodist, United States.
How many publications and citations does James M. Musser have?
OpenAlex counts 567 works and 50,040 citations for James M. Musser, an h-index of 125, ranking #14,161 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about James M. Musser. Posts are plain text and can be reported.